Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study

  1. Yoshino, T.
  2. Portnoy, D.C.
  3. Obermannová, R.
  4. Bodoky, G.
  5. Prausová, J.
  6. Garcia-Carbonero, R.
  7. Ciuleanu, T.
  8. García-Alfonso, P.
  9. Cohn, A.L.
  10. Van Cutsem, E.
  11. Yamazaki, K.
  12. Lonardi, S.
  13. Muro, K.
  14. Kim, T.W.
  15. Yamaguchi, K.
  16. Grothey, A.
  17. O'Connor, J.
  18. Taieb, J.
  19. Wijayawardana, S.R.
  20. Hozak, R.R.
  21. Nasroulah, F.
  22. Tabernero, J.
Journal:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Year of publication: 2019

Volume: 30

Issue: 1

Pages: 124-131

Type: Article

DOI: 10.1093/ANNONC/MDY461 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus